Puretech Health PLC (LON:PRTC) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 144 ($1.94) and last traded at GBX 141.70 ($1.91), with a volume of 34006 shares traded. The stock had previously closed at GBX 137.25 ($1.85).

A number of equities research analysts recently weighed in on PRTC shares. Peel Hunt reissued a “buy” rating and issued a GBX 278 ($3.74) price target on shares of Puretech Health in a research report on Monday, November 20th. Jefferies Group reissued a “buy” rating on shares of Puretech Health in a research report on Friday, November 17th. N+1 Singer reissued a “buy” rating on shares of Puretech Health in a research report on Monday, September 25th. Numis Securities reissued a “buy” rating and issued a GBX 207 ($2.79) price target on shares of Puretech Health in a research report on Monday, September 25th. Finally, Liberum Capital reissued a “buy” rating and issued a GBX 248 ($3.34) price target on shares of Puretech Health in a research report on Monday, September 25th. Five analysts have rated the stock with a buy rating, Puretech Health presently has a consensus rating of “Buy” and an average target price of GBX 248 ($3.34).

TRADEMARK VIOLATION WARNING: This piece was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/12/14/puretech-health-prtc-sets-new-12-month-high-at-144-00.html.

About Puretech Health

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Receive News & Ratings for Puretech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health and related companies with MarketBeat.com's FREE daily email newsletter.